Trends in Microbiology
Volume 1, Issue 8, November 1993, Pages 317-320
Journal home page for Trends in Microbiology

Opinion
Avirulent mutants of rabies virus and their use as live vaccine

https://doi.org/10.1016/0966-842X(93)90010-OGet rights and content

Abstract

Oral vaccination of foxes against rabies began in Switzerland some 20 years ago and was later extended to several European countries. The vaccine strains, which were derivatives of the SAD strain of rabies, retain a non-negligible pathogenicity for rodents and nontarget species. Antigenic mutants of the SAD Bern vaccine strain, which are avirulent for adult mice, foxes and dogs, have been isolated and are presently under trial.

References (15)

  • F. Lafay

    Virology

    (1991)
  • C. Tuffereau

    Virology

    (1989)
  • E.H. Follmann et al.

    Vaccine

    (1992)
  • J.G. Debbie et al.

    Am. J. Epidemiol.

    (1972)
  • A.I. Wandeler

    Rev. Infect. Dis.

    (1988)
  • H. Leblois et al.
  • P. Coulon

    J. Gen. Virol.

    (1982)
There are more references available in the full text version of this article.

Cited by (28)

  • Advances in rabies prophylaxis and treatment with emphasis on immunoresponse mechanisms

    2018, International Journal of Veterinary Science and Medicine
    Citation Excerpt :

    However, they are still expensive as the given doses must be repeated for at least 3–4 weeks, and must be stored in refrigerators which is not practical everywhere in Africa and Asia where it is needed. Moreover, they deliver poor immune response in malnourished animals or humans [20,48–52]. The fourth stage in the development of rabies vaccines started with the evolution of DNA recombinant technology.

  • Animal Rabies

    2003, Rabies
View all citing articles on Scopus
View full text